OOIR: Observatory of International Research

Papers

(The TQCC of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION	72
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS	50
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE	30
IFC Editorial Board	28
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION	25
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN	22
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA	22
Neutrophil death-more than meets the eye	20
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE	20
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e5	18
RNA methylation: where to from here for hematologic malignancies?	18
3077 – FUNCTIONAL AND MOLECULAR IDENTIFICATION OF A FETAL-ASSOCIATED TUMOR SUPPRESSOR AXIS: ABROGATION OF MLL-ENL DRIVEN ACUTE MYELOID LEUKEMIA	17
3136 – LOSS OF CD36 EXPRESSION HAS LIMITED IMPACT ON NORMAL HEMATOPOIESIS	17
3010 – REJUVENATING BLOOD STEM CELLS EXTENDS LIFESPAN OF AGED IMMUNOCOMPROMISED MICE	17
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]	16
3163 – MODULATION OF RNA POLYMERASE II ACTIVITY REGULATES HUMAN HSC SELF-RENEWAL	16
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.	16
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO	16
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING	15
3219 – RNA DEADENYLATION SUBUNIT CNOT3 PROMOTES MYELOID LEUKEMIA BY DRIVING TRANSLATION OF ONCOGENIC TARGETS	15
1022 – GENE THERAPY FOR BETA-THALASSEMIA: FROM THE BENCH TO THE BEDSIDE AND BACK	15
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS	15
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL	14
1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS	13
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs	13

3054 – CROSSTALK AT THE MATERNAL-FETAL INTERFACE CONSTRAINS FETAL HEMATOPOIETIC STEM AND PROGENITOR CELL RESPONSE TO INFLAMMATION.	13
Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis	12
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes	12
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage	12
3127 – INDUCTION OF ONTOGENY-SPECIFIC CD24+ PRELEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL	12
3131 – DISPARITIES IN IMMUNOSUPPRESSIVE PROFILES BETWEEN RELAPSED AML WITH OR WITHOUT ALLO-HCT	12
3008 – INTEGRATED IN SILICO AND IN VITRO APPROACHES MATCH DEVELOPMENTAL CELL-OF-ORIGIN TO THERAPEUTIC VULNERABILITIES IN INFANT LEUKEMIA	12
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS	11
Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis	11
3133 – UNCOVERING DISTINCT METABOLIC PROPERTIES OF RELAPSE AND RELAPSE-FATED CLONES IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA	11
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA	11
3055 – THE 3′ DISTAL ENHANCER REGION OF THE CEBPB GENE IS ESSENTIAL FOR MONOCYTE DEVELOPMENT	11
Effect of peritransplant measurable residual disease clearance in patients with myelodysplastic neoplasm: a referral center experience	10
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis	10
A new era of functional experimentation in human hematopoiesis and leukemia research	10
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms	10
Cover 2: Editorial Board	10
3114 – FROM MECHANISMS OF LEUKAEMOGENIC DYSREGULATION TO NEW CANDIDATE THERAPEUTICS	10
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION	9
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA	9
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL1	9
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS	9
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES	9
Cover 2: Editorial Board	9
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION	9
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION	9
2019 – SYSTEMIC AND LOCAL REGULATION COOPERATES TO DETERMINE HEMATOPOIETIC STEM CELL NUMBERS	8
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY	8
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing	8
3065 – CRISPR MODELING OF ACUTE MYELOID LEUKEMIA MUTATIONS IN PRIMARY HEMATOPOIETIC STEM CELLS TO STUDY (PRE-)LEUKEMIA DEVELOPMENT	8
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS	8
3006 – JAK2 PHOSPHORYLATES THE RNA PROCESSING PROTEIN HNRNPA1 TO REPRESS THE EXPRESSION OF RETROTRANSPOSONS AND PROTECT THE HAEMATOPOIETIC STEM CELL GENOME	8
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT	8
Ontogeny, dynamics, and characteristics of neutrophils during the perinatal period	8
3040 – DRUG DISCOVERY FOR INHIBITORS OF PHAGOCYTOSIS FOR USE IN IMMUNE CYTOPENIAS	8
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW	8
3195 – LONG-TERM EX VIVO HEMATOPOIETIC STEM CELL (HSC) EXPANSION USING NOVEL BONE-LINING REINVIGORATING MESENCHYMAL STROMAL CELLS (RMSCS)	8
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment	8
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia	7
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes	7
1006 – HEMATOPOIETIC STEM CELL ACTIVATION FOR BLOOD REGENERATION	7
3144 – GRX1 DEGLUTATHIONYLATES NF-κB P65 TO INCREASE LAG3 EXPRESSION IN T CELLS AND PROMOTE TUMOR GROWTH	7
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy	7
Building bones for blood and beyond: the growing field of bone marrow niche model development	7
3004 – IN VITRO EXPANDED HEMATOPOIETIC STEM CELLS COMBINED WITH NON-GENOTOXIC CONDITIONING ENABLE EFFICIENT TRANSPLANTATION AND SUPPRESS MYELOID DISEASE	7
Integrins and their role in megakaryocyte development and function	7
ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming	7
1005 – MAPPING THE DEVELOPMENTAL PATHWAYS TO HUMAN HEMATOPOIETIC AND LEUKEMIC STEM CELLS	7
3089 – AN ITGB3 CYTOPLASMIC MUTATION CAUSES MACROTHROMBOCYTOPENIA VIA IMPAIRED αIIBβ3–RHOA SIGNALING	7
3187 – MECOM PROMOTES LEUKEMIA PROGRESSION AND INHIBITS MAST CELL DIFFERENTIATION THROUGH FUNCTIONAL COMPETITION WITH GATA2	6

1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION	6
3085 – THERMAL PROTEOME IDENTIFIES KEY REGULATORS IN HEMATOPOIETIC STEM CELLS	6
3138 – LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS	6
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells	6
3185 – A MACHINE LEARNING PIPELINE UNCOVERS LAG-3-MEDIATED IMMUNOREGULATION IN INFLAMMATORY HSCs	6
3129 – PREEMPTIVE TARGETING OF PRELEUKEMIC CELLS IN DOWN SYNDROME WITH PATHWAY-DIRECTED THERAPIES: A NOVEL APPROACH TO PREVENT MYELOID LEUKEMIA	6
2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA.	6
3218 – LYL1 IS CRITICAL FOR ADULT HEMATOPOIETIC STEM CELL-DERIVED B- AND T-LYMPHOPOIESIS	6
3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING	5
3215 – A SINGLE-CELL EXPRESSION ATLAS OF HUMAN AML LEUKEMIA-INITIATING CELLS UNRAVELS THE CONTRIBUTION OF HIF PATHWAY AND ITS THERAPEUTIC POTENTIAL	5
1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS	5
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA	5
3056 – VITAMIN C LIMITS MULTIPOTENT PROGENITOR SELF-RENEWAL AND CLONAL EXPANSION	5
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)	5
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL	5
3209 – SINGLE-CELL PROFILING OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS A GRADUAL TRANSITION FROM PRE-LEUKEMIA TO LEUKEMIA	5
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro	5
3122 – SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA	5
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE	5
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES	5
3210 – BIOLOGY AND FUNCTION OF CIRCULAR PCMDT1 (CP1) IN CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)	5
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia	5
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY	5
3119 – DECIPHERING THE IMPACT OF TYPE 1 INTERFERON IN HUMAN CALR-MUTATED AND WILDTYPE HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELOPROLIFERATIVE NEOPLASMS VIA SINGLE-CELL MULTI-OMICS	5
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS	5
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL	5
3204 – NK CELL-DEFECTS OCCURRING ALREADY AT THE PRE-MDS STAGE IN NUP98-HOXD13 TRANSGENIC MOUSE MODEL	5
Development and aging of resident endothelial stem cells in pre-existing blood vessels	4
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis	4
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS	4
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION	4
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION	4
1032 – STEM CELLS IN HUMAN AML	4
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION	4
Analysis of risk factors for early death of lymphocyte subsets in adult patients with secondary hemophagocytic lymphohistiocytosis	4
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes	4
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES	4
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study	4
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION	4
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS	4
3052 – PLZF LOSS-OF-FUNCTION ALTERS THE HEMATOPOIETIC STEM CELL COMPARTMENT IN AN AGE-DEPENDENT MANNER	4
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS	4
3193 – THE FUNCTIONAL ROLE OF NUCLEAR PROTEIN 1 (NUPR1) IN AGE-RELATED HEMATOPOIETIC STEM CELL FATE PRIMING	4
3151 – PUTTING THE STING BACK INTO THERAPY FOR P53 MUTANT BLOOD CANCERS	4
Immune control in acute myeloid leukemia	4
3222 – THE SURROGATE HEMATOPOIETIC STEM CELL NICHE AS A TOOL TO UNDERSTAND HEMATOPOIETIC STEM CELL EXPANSION	4
3104 – TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF MURINE FETAL LIVER HEMATOPOIETIC STEM CELLS AT SINGLE CELL RESOLUTION	4
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.	4
2006 – RAS MUTATIONS TRANSFORM GRANULOCYTE-MONOCYTE PROGENITORS INTO INFLAMMATORY LEUKEMIA STEM CELLS IN ACUTE MYELOID LEUKEMIA	4
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS	4
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY	4
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV	4
3163 – ANTI-CD69 MONOCLONAL ANTIBODY AVENUE DISEASE PROGRESSION IN A MOUSE MODEL OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH NRASG12D MUTATION	4
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS	3
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES	3
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT	3
3090 – CLONAL RECONSTRUCTION FROM CO-OCCURRENCE OF VECTOR INTEGRATION SITES ALLOWS ACCURATE QUANTIFICATION OF EXPANDING CLONES IN VIVO	3
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY	3
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells	3
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils	3
3057 – HIGH SALT DIETS PROMOTE A TH17 CELL DRIVEN GUT-BONE AXIS TO REGULATE HAEMATOPOIESIS AND ATHEROSCLEROSIS	3
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells	3
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS	3
3093 – SUBTYPE-SPECIFIC INDUCTION OF MITOCHONDRIAL APOPTOSIS AS A NOVEL THERAPEUTIC OPTION IN HIGH-FATALITY PEDIATRIC LEUKEMIA	3
3002 – CIRCADIAN CUES REPROGRAM METABOLIC PATHWAYS IN LONG-TERM REPOPULATING HEMATOPOIETIC STEM CELLS	3
3060 – PDGFRΒ+ CELLS PLAY A DUAL ROLE AS HEMATOPOIETIC PRECURSORS AND NICHE CELLS DURING MOUSE ONTOGENY	3
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS	3
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA	3
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE	3
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells	3
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA	3
Functional and molecular profiling of hematopoietic stem cells during regeneration	3
Assay optimization for the objective quantification of human multilineage colony-forming units	3
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA	3
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice	3
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy	3
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.	3
3048 – MECHANISMS AND PROGNOSIS OF A20 MUTATION AND ABNORMAL EXPRESSION IN T-CELL MALIGNANCIES	3
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS	3
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS	3

2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION	3
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING	3
3074 – GLOBAL EPIGENOMIC REGULATION OF GENE EXPRESSION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY IKAROS	3
Mtg16 NHR1 mutations cause defects in lymphopoiesis and the response to anemia	3
3203 – IDENTIFICATION OF DIFFERENTIATION ROOTS OF HEMATOPOIETIC STEM CELLS BY A PAIRED-DAUGHTER ASSAY COMBINED WITH MULTIPLE BARCODING	3
C-COUNT: a convolutional neural network–based tool for automated scoring of erythroid colonies	3
3041 – CELLULAR MECHANISMS INVOLVED IN SERONEGATIVE HEMOLYTIC ANEMIAS	3
Short Talk Presentations	3
2022 – CHARACTERIZING HETEROGENEITY IN HEALTHY AND MALIGNANT HEMATOPOIETIC HIERARCHIES USING SINGLE CELL PROTEOMICS	3
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS	2
3076 – EARLY MYELOID COMMITMENT OF HSCS: MAFB AS A MASTER REGULATOR?	2
1024 – A GENETIC LABELING STRATEGY FOR COMPETITIVE XENOTRANSPLANTATION OF HUMAN HSCS	2
3021 – EX VIVO EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS	2
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization	2
Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis	2
2001 – THE ENDOSOMAL ADAPTOR PROTEIN MYCT1 CONTROLS ENVIRONMENTAL SENSING IN HUMAN HEMATOPOIETIC STEM CELLS	2
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer	2
3061 – STROMAL CELL-TRIGGERED DOWNREGULATION OF THE NUCLEOPORIN (NUP) FAMILY DRIVES TRANSFORMATION OF MYELODYSPLASIA TO ACUTE MYELOID LEUKEMIA	2
1018 – HETEROGENEITY AND FUNCTIONAL SPECIALIZATION OF THE BONE MICROVASCULATURE	2
3221 – INVESTIGATING THE ROLE OF UBIQUITIN E3 LIGASE, FBXO21, IN THE REGULATION OF CYTOKINE SIGNALING WITHIN ACUTE MYELOID LEUKEMIA	2
3051 – HEMATOPOIETIC STEM CELLS DEPEND ON AUTOPHAGY TO MAINTAIN PROTEIN HOMEOSTASIS	2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone	2
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS	2
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	2
3097 – CLONAL COMPETITION, FITNESS, AND MUTATION TIMING DRIVE ADVERSE OUTCOMES IN CLONAL HEMATOPOIESIS	2
Fetal allotransplant recipients are resistant to graft-versus-host disease	2
3201 – HEMATOPOIETIC STEM CELL-DERIVED CAR-IMMUNE SYSTEM FOR TUMOR IMMUNOTHERAPY	2
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent	2
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION	2
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS	2
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT	2
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS	2
3081 – LCK DRUG TARGETING IN PAX5 REARRANGED CASES IN POOR RISK CHILDHOOD B-CELL PRECURSORS ACUTE LYMPHOBLASTIC LEUKAEMIA	2
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS	2
3021 – SINGLE-CELL RNASEQ REVEALS CELL ADHESION MOLECULE PROFILES OF SHORT-TERM AND LONG-TERM CORD BLOOD HEMATOPOIETIC STEM CELLS	2
3184 – ONCOSTATIN M SIGNALING MEDIATES DNMT3A-MUTANT HEMATOPOIETIC STEM CELL FITNESS IN THE AGED BONE MARROW MICROENVIRONMENT	2
3106 – GENOME-WIDE CRISPR SCREENING IDENTIFIES THE E3 UBIQUITIN LIGASE HERC1 AS A MODULATOR OF THE RESPONSE TO NUCLEOSIDE ANALOGS IN ACUTE MYELOID LEUKEMIA	2
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT	2
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL	2
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR	2
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL	2
3003 – MASS SPECTROMETRY-BASED PROFILING OF BONE MARROW NICHE SECRETOME REMODELING IN AGING AND TET2-MUTANT CLONAL HEMATOPOIESIS	2
3180 – SRSF2 P95H AND NF1 DEFICIENCY SYNERGIZE TO PROMOTE MYELOID-BIASED CLONAL HEMATOPOIESIS FROM HEMATOPOIETIC STEM CELLS VIA JAK-STAT ACTIVATION IN MICE	2
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs	2
3173 – HAPLODEFICIENCY OF THE MTAP/CDKN2 LOCUS DRIVES IMMUNOMETABOLIC DYSREGULATION AND STROMAL CELL ALTERATIONS LEADING TO MYELODYSPLASTIC SYNDROMES-LIKE DISEASE	2
Cover 2: Editorial Board	2
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS	2
1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND	2
3223 – THE DEVELOPMENT OF A DIAGNOSTIC TOOL TO HELP PRIMARY CARE CLINICIANS MANAGE PATIENTS WITH SUSPECTED MYELOMA	2
3232- – INFLAMMATORY STRESS PROMOTES HETEROGENEOUS ACTIVATION OF IMMUNE RESPONSE PROGRAMS IN HUMAN HEMATOPOIETIC STEM CELLS	2
3148 – GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS	2
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.	2
From Metcalf to myeloproliferative neoplasms – a personal journey	2
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT	2
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION	2
3128 – HYALURONIC ACID- GPRC5C SIGNALLING PROMOTES DORMANCY IN HEMATOPOIETIC STEM CELLS	1
3125 – ANTIFUNGALS CLOTRIMAZOLE AND ECONAZOLE NITRATE EFFECTIVELY TARGET A METABOLIC VULNERABILITY OF PAEDIATRIC ACUTE MYELOID LEUKAEMIA (PAML) WITH CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN VITRO.	1
3104 – FITNESS IS A BETTER PREDICTOR OF OUTCOMES IN CLONAL HEMOPOIESIS COMPARED TO CLONE SIZE	1
3126 – PERSISTENT METABOLIC DEFLATION OF HEMATOPOIETIC STEM CELLS (HSCS) AFTER CHEMOTHERAPY CAUSES PREMATURE HEMATOPOIETIC AGEING	1
CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis	1
3247 – A PROMISING PLANT ALKALOID PROVIDES NEUROPROTECTION AGAINST AΒ-INDUCED TOXICITY IN SH-SY5Y CELLS	1
3158 – VENETOCLAX AND PROTEASOME INHIBITORS SYNERGISTICALLY INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA	1
2024 – A STEP-WISE AND DETERMINISTIC LEUKEMIA MOUSE MODEL REMINISCENT OF JMML WITH ENDOGENOUS ACQUISITION OF PATIENT-RELEVANT RTK–RAS MUTATIONS	1
1019 –	1
1012 – DEVELOPMENTAL PROGRAMMING OF TISSUE-RESIDENT MACROPHAGES	1
Balancing hematopoietic stem cell self-renewal and differentiation activities throughout ontogeny and aging	1
3181 – CRISPR/CAS9-MEDIATED CORRECTION OF FANCC GENE RESCUES THE INDUCED BONE MARROW FAILURE IN FANCC-/- MOUSE	1
2001 – EMBRYONIC MACROPHAGES REGULATE THE SIZE OF THE DEFINITIVE HSC POOL	1
3012 – IL-27 REGULATES MONOCYTE DEVELOPMENT AND FUNCTION DURING ACUTE TOXOPLASMA GONDII INFECTION	1
3167 – NOTCH3 C455R EXPRESSION IN THE MURINE HEMATOPOIETIC SYSTEM RESULTS IN CLONAL HAEMATOPOIESIS AND A PERTURBED INFLAMMATORY MILIEU	1
3139 – DEFECTIVE MYELOID LINEAGE PRIMING AND GENOME INSTABILITY UNDERLIE MARROW FAILURE IN A ZEBRAFISH GATA2 DEFICIENCY MODEL	1
3124 – NOVEL REGULATORY MECHANISM OF HEMOGENIC ENDOCARDIUM DURING CARDIOVASCULAR DEVELOPMENT	1
Cover 2: Editorial Board	1
The multifaceted role of mitochondria in HSC fate decisions: energy and beyond	1
3099 – CYTOPLASMIC LOCALIZATION OF THE POLYCOMB PROTEIN CBX7 BLOCKS LEUKEMIC CELL GROWTH.	1
3099 – REGULATORY ROLE OF 3D DNA STRUCTURE IN HEMATOPOIESIS AND LEUKEMOGENESIS	1
1011 – MULTIPLEXING SPATIAL TRANSCRIPTOMICS, 4D IN SITU INTRAVITAL DATA AND 3D IMAGING TO DEFINE BONE MARROW MICROENVIRONMENTS IN INFLAMMATION AND BLOOD CANCER	1
2026 – A CANCER IMMUNOTHERAPY MODALITY BASED ON DENDRITIC CELL REPROGRAMMING IN VIVO	1
3014 – MEAN PLATELET VOLUME - A NOVEL BIOMARKER IN VARIOUS CARDIOVASCULAR DISEASES	1
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation	1
3175 – TUNEABLE HYDROGELS AS A NEW TOOL TO EXPLORE EXTRACELLULAR MATRIX PROTEINS IN MALIGNANCY	1
3103 – INHIBITING MAST CELL FUNCTION TO PROMOTE HEMATOPOIETIC REGENERATION FOLLOWING INJURY	1
3126 – RUNX FACTORS REGULATE EX VIVO HAEMATOPOIETIC STEM CELL EXPANSION	1
3090 – HEMATOPOIETIC STEM AND PROGENITOR CELL VESICLES PRE-CONDITION THE BONE MARROW NICHE DURING TRANSPLANTATION	1
3124 – GRANULOCYTE COLONY-STIMULATING FACTOR MODIFIES THE IN VITRO DIFFERENTIATION OF HUMAN PRIMITIVE ERYTHROID PROGENITOR CELLS	1
Cover 2: Editorial Board	1
3145 – SINGLE-CELL RNA SEQUENCING REVEALS GATA3 REGULATES DIFFERENTIATION OF REGULATORY T CELLS IN AML	1
Nucleic acid metabolism: the key therapeutic target for myeloid tumors	1
3171 – GLYCOLYSIS DRIVES IL-6 PRODUCTION BY BONE MARROW STROMAL CELLS DURING ACUTE INFLAMMATION	1
3246 – DEVELOPMENTAL AND FUNCTIONAL ANALYSIS OF MONOCYTES AND MACROPHAGES IN ZEBRAFISH DURING HEART REGENERATION	1
2019 – ENDOTHELIAL CELL-DERIVED THROMBOSPONDIN-1 NEGATIVELY AFFECTS HEMATOPOIETIC FUNCTION DURING AGING	1
3187 – IKAROS LOSS ENHANCES PRE-LEUKEMIC THYMOCYTE SELF-RENEWAL AND DRIVES T-ALL IN MICE	1
3235 – HYPERDIPLOIDY IMPAIRS FETAL HSPC FITNESS AND DIFFERENTIATION ENABLING LONG-TERM PERSISTENCE OF RARE PRELEUKEMIC TRISOMIC CLONES IN BONE MARROW	1
3200 – USING QUANTITATIVE PROTEOMICS TO IDENTIFY NEW THERAPEUTIC TARGETS IN MANTLE CELL LYMPHOMA	1
3055 – ENHANCING TRANSLATION FIDELITY EXTENDS HEMATOPOIETIC STEM CELL LONGEVITY	1